Synaptogenix (TAOX) Competitors $6.21 +0.05 (+0.81%) As of 09/12/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsSEC FilingsShort InterestTrendsBuy This Stock TAOX vs. VXRT, WHWK, OKYO, ELUT, SLGL, AVTE, PMVP, UNCY, ASRT, and IGMSShould you be buying Synaptogenix stock or one of its competitors? The main competitors of Synaptogenix include Vaxart (VXRT), Whitehawk Therapeutics (WHWK), OKYO Pharma (OKYO), Elutia (ELUT), Sol-Gel Technologies (SLGL), Aerovate Therapeutics (AVTE), PMV Pharmaceuticals (PMVP), Unicycive Therapeutics (UNCY), Assertio (ASRT), and IGM Biosciences (IGMS). These companies are all part of the "pharmaceutical products" industry. Synaptogenix vs. Its Competitors Vaxart Whitehawk Therapeutics OKYO Pharma Elutia Sol-Gel Technologies Aerovate Therapeutics PMV Pharmaceuticals Unicycive Therapeutics Assertio IGM Biosciences Synaptogenix (NASDAQ:TAOX) and Vaxart (NASDAQ:VXRT) are both small-cap pharmaceutical products companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, dividends, analyst recommendations, earnings, risk, profitability and valuation. Does the media refer more to TAOX or VXRT? In the previous week, Vaxart had 4 more articles in the media than Synaptogenix. MarketBeat recorded 6 mentions for Vaxart and 2 mentions for Synaptogenix. Synaptogenix's average media sentiment score of 0.95 beat Vaxart's score of 0.53 indicating that Synaptogenix is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Synaptogenix 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Vaxart 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable valuation & earnings, TAOX or VXRT? Synaptogenix has higher earnings, but lower revenue than Vaxart. Vaxart is trading at a lower price-to-earnings ratio than Synaptogenix, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSynaptogenixN/AN/A-$12.77M-$20.16-0.31Vaxart$47.40M1.88-$66.95M-$0.25-1.56 Do analysts prefer TAOX or VXRT? Vaxart has a consensus price target of $2.00, indicating a potential upside of 412.82%. Given Vaxart's stronger consensus rating and higher probable upside, analysts clearly believe Vaxart is more favorable than Synaptogenix.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Synaptogenix 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Vaxart 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders & institutionals have more ownership in TAOX or VXRT? 10.3% of Synaptogenix shares are owned by institutional investors. Comparatively, 18.0% of Vaxart shares are owned by institutional investors. 2.7% of Synaptogenix shares are owned by company insiders. Comparatively, 2.8% of Vaxart shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has more volatility and risk, TAOX or VXRT? Synaptogenix has a beta of 1.87, indicating that its share price is 87% more volatile than the S&P 500. Comparatively, Vaxart has a beta of 1.33, indicating that its share price is 33% more volatile than the S&P 500. Is TAOX or VXRT more profitable? Synaptogenix has a net margin of 0.00% compared to Vaxart's net margin of -122.63%. Vaxart's return on equity of -91.89% beat Synaptogenix's return on equity.Company Net Margins Return on Equity Return on Assets SynaptogenixN/A -277.76% -150.79% Vaxart -122.63%-91.89%-38.40% SummaryVaxart beats Synaptogenix on 10 of the 15 factors compared between the two stocks. Get Synaptogenix News Delivered to You Automatically Sign up to receive the latest news and ratings for TAOX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TAOX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TAOX vs. The Competition Export to ExcelMetricSynaptogenixPharmaceutical Preparations IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$21.48M$934.71M$2.55B$10.14BDividend YieldN/A4.84%2.51%4.59%P/E Ratio-0.311.1026.2825.93Price / SalesN/A26.70112.42198.13Price / CashN/A19.5649.2160.44Price / Book1.436.6934.656.29Net Income-$12.77M-$4.50M$16.40M$270.77M7 Day Performance0.32%8.75%1.79%3.88%1 Month Performance-35.04%9.50%3.63%4.88%1 Year PerformanceN/A22.47%34.18%26.01% Synaptogenix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TAOXSynaptogenix0.1181 of 5 stars$6.21+0.8%N/AN/A$21.48MN/A-0.314Positive NewsVXRTVaxart2.0502 of 5 stars$0.38-0.1%$2.00+431.5%-57.0%$86.15M$47.40M-1.39120Gap DownWHWKWhitehawk Therapeutics1.1984 of 5 stars$1.82+0.6%N/AN/A$85.77M$25.98M-30.3321OKYOOKYO Pharma2.2266 of 5 stars$2.26+0.4%$7.00+209.7%+107.7%$85MN/A0.007Short Interest ↑ELUTElutia3.1041 of 5 stars$1.88-6.5%$8.00+325.5%-70.6%$79.70M$24.38M-1.77180Analyst ForecastHigh Trading VolumeSLGLSol-Gel Technologies0.7724 of 5 stars$27.96-0.1%N/A+290.9%$77.89M$11.54M-22.7350Positive NewsAnalyst UpgradeShort Interest ↑Gap DownAVTEAerovate TherapeuticsN/A$7.77-0.1%N/A-88.2%$77.68MN/A-2.6020Positive NewsHigh Trading VolumePMVPPMV Pharmaceuticals2.8446 of 5 stars$1.46+1.4%$5.50+276.7%-17.4%$77.37MN/A-0.9350News CoverageInsider TradeUNCYUnicycive Therapeutics1.9644 of 5 stars$4.36+0.9%$60.00+1,276.1%+1.8%$77.01M$680K-1.069ASRTAssertio1.7507 of 5 stars$0.80-1.2%$2.38+197.7%-36.0%$76.78M$117.10M-1.7720IGMSIGM Biosciences4.0669 of 5 stars$1.27flat$4.89+285.0%N/A$76.57M$145.05M-1.41190 Related Companies and Tools Related Companies Vaxart Alternatives Whitehawk Therapeutics Alternatives OKYO Pharma Alternatives Elutia Alternatives Sol-Gel Technologies Alternatives Aerovate Therapeutics Alternatives PMV Pharmaceuticals Alternatives Unicycive Therapeutics Alternatives Assertio Alternatives IGM Biosciences Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TAOX) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synaptogenix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Synaptogenix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TAOX Stock Alerts